The expression pattern of GLI signaling components was tested in established cervical cancer cell lines, C33a, SiHa, HeLa and CaSki along with other cancer cells MDA-MB-231 (breast cancer) and HaCaT (immortalized Keratinocytes) that were used as control (Fig. 1a). This evidence concerns the gene GLI1 and cancer.